Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | CVP,PRES - CODMAN SPC SURGICAL | May 11, 2020 | May 13, 2020 |
| Neuronetics, Inc.STIM · Entity 6248 | President and CEO | March 23, 2026 | March 23, 2026 |
| TACTILE SYSTEMS TECHNOLOGY INCTCMD · Entity 5451 | Director | March 11, 2025 | March 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date May 11, 2020 · Filed May 13, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,473 |
Ending reported balance
After 2020-05-11 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2020-05-11 · Exercise / conversion · Acquired 2,420 · Balance 44,893 Row 2 · 2020-05-11 · Sale · Disposed 2,420 · Balance 42,473 F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Row 3 · 2020-05-11 · Exercise / conversion · Acquired 4,978 · Balance 47,451 Row 4 · 2020-05-11 · Sale · Disposed 4,978 · Balance 42,473 F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Row 5 · 2020-05-11 · Exercise / conversion · Acquired 10,446 · Balance 52,919 Row 6 · 2020-05-11 · Sale · Disposed 10,446 · Balance 42,473 F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Row 7 · 2020-05-11 · Exercise / conversion · Acquired 5,486 · Balance 47,959 Row 8 · 2020-05-11 · Sale · Disposed 5,486 · Balance 42,473 F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.87 · Expires 2023-03-23 | Direct | 0 |
Reported balance
After 2020-05-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-05-11 · Exercise / conversion · Disposed 2,420 · Balance 0 F2: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/23/2015. F3: This stock option was previously reported as covering 1,047 shares of common stock at an exercise price of $62.10 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015. F4: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.59 · Expires 2024-03-14 | Direct | 0 |
Reported balance
After 2020-05-11 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2020-05-11 · Exercise / conversion · Disposed 5,486 · Balance 0 F5: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/14/2016. F4: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.43 · Expires 2024-12-01 | Direct | 0 |
Reported balance
After 2020-05-11 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-05-11 · Exercise / conversion · Disposed 10,446 · Balance 0 F6: 100% of the shares of stock options will vest on the third anniversary of the grant date of 12/01/2016. F4: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.68 · Expires 2025-03-13 | Direct | 1,660 |
Reported balance
After 2020-05-11 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2020-05-11 · Exercise / conversion · Disposed 4,978 · Balance 1,660 F7: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/13/2017. |
| Common StockSEC Table I · non-derivative | IndirectBy Children | 200 |
Reported balance
Holding disclosure · report date 2020-05-11 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 200 |
Filing footnotes · ownership attribution and instrument terms
F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871.
F2: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/23/2015.
F3: This stock option was previously reported as covering 1,047 shares of common stock at an exercise price of $62.10 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.
F4: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
F5: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/14/2016.
F6: 100% of the shares of stock options will vest on the third anniversary of the grant date of 12/01/2016.
F7: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/13/2017.
Neuronetics, Inc.
Report date March 23, 2026 · Filed March 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,500,000 |
Reported balance
After 2026-03-23 transaction · row 1
1 source rowRow 1 · 2026-03-23 · Grant · Acquired 1,500,000 · Balance 1,500,000 F1: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on March 23, 2027, in each case subject to continuous service of the Reporting Person through such date. F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on March 23, 2027, in each case subject to continuous service of the Reporting Person through such date.
F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
TACTILE SYSTEMS TECHNOLOGY INC
Report date March 11, 2025 · Filed March 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 146,442 |
Reported balance
After 2025-03-11 transaction · row 1
1 source rowRow 1 · 2025-03-11 · Gift · Disposed 68,162 · Balance 146,442 |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 68,162 |
Reported balance
After 2025-03-11 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2025-03-11 · Gift · Acquired 68,162 · Balance 68,162 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2026 Filed Mar 23, 2026 20:41 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 1,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001563602-26-000006 · ownership.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500,000 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on March 23, 2027, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:20 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GiftCommon Stock | 68,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-007530 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 68,162 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:20 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GiftCommon Stock | 68,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-007530 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,442 Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:27 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 28,338 | $14.18 | $401,849.84 |
DisclosureSEC source: 0001437749-25-005481 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,604 F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-10-2024 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F3 · price: Reflects the weighted average price of 28,338 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 25, 2025 with sale prices ranging from $14.09 to $14.49 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 24, 2025 Filed Feb 24, 2025 23:24 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 10,938 | $14.55 | $159,146.81 |
DisclosureSEC source: 0001437749-25-004938 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 242,942 F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-10-2024 F3 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F4 · price: Reflects the weighted average price of 10,938 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2025 with sale prices ranging from $14.50 to $14.61 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 23:24 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 15,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-004938 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 253,880 F1 · shares: On February 22, 2023, the reporting person was granted performance stock units ("PSUs"), with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2024. As determined on February 20, 2025, based on actual performance for 2024, the reporting person earned 15,853 PSUs. Those earned PSUs vested on February 20, 2025. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 01:42 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 1,396 | $15.25 | $21,289.00 |
DisclosureSEC source: 0001437749-24-006205 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,027 F3 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units, which sales were pursuant to Rule 10b5-1 instructions on February 25, 2021. F4 · shares: Adoption date of referenced 10b5-1(c) plan is: 02-24-2022. Read SEC document |
| February 27, 2024 Filed Mar 1, 2024 01:42 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 4,689 | $15.60 | $73,148.40 |
DisclosureSEC source: 0001437749-24-006205 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 239,423 F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units, which sales were pursuant to Rule 10b5-1 instructions on February 24, 2022. F2 · shares: Adoption date of referenced 10b5-1(c) plan is: 02/24/2022. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 02:13 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 6,239 | $15.81 | $98,644.83 |
DisclosureSEC source: 0001437749-24-005784 · rdgdoc.xml · nonDerivative · entry 4 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 244,112 F6 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units, which sales were pursuant to Rule 10b5-1 instructions on February 25, 2021 and February 24, 2022. F7 · price: Reflects the weighted average price of 6,239 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 26, 2024 with sale prices ranging from $15.79 to $15.875 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 24, 2024 Filed Feb 28, 2024 02:13 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 13,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-005784 · rdgdoc.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 250,351 F5 · shares: On February 22, 2023, the reporting person was granted PSUs, with the number of PSUs earned to be determined based on the extent to which certain performance conditions are met for a performance period consisting of three separate performance years of 2023, 2024 and 2025. As determined on February 24, 2024, based on actual performance for 2023, the reporting person earned 13,100 PSUs with respect to the 2023 performance year. Those PSUs are scheduled to vest on the date in 2025 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2024 performance year. Read SEC document |
| February 24, 2024 Filed Feb 28, 2024 02:13 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 44,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-005784 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 237,251 F4 · shares: On February 24, 2022, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023. As determined on February 24, 2024, based on actual performance for 2023, the reporting person earned 44,930 PSUs. Of those earned PSUs, one-third, or 14,977 PSUs, vested on February 24, 2024, and the remaining two-thirds, or 29,953 PSUs, are scheduled to vest on February 24, 2025. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:13 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 5,378 | $14.85 | $79,852.54 |
DisclosureSEC source: 0001437749-24-005784 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 192,321 F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units, which sales were pursuant to a Rule 10b5-1 instruction on February 22, 2023. F2 · shares: Adoption date of referenced 10b5-1(c) plan is: 02-22-2023. F3 · price: Reflects the weighted average price of 5,378 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2024 with sale prices ranging from $14.84 to $14.89 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 21, 2024 Filed Feb 24, 2024 01:25 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 72,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-005438 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,699 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 20:10 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 1,062 | $20.53 | $21,807.64 |
DisclosureSEC source: 0001437749-23-022794 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,653 F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F2 · price: Reflects the weighted average price of 1,062 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on August 7, 2023 with sale prices ranging from $20.5304 to $20.56 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 01:36 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 700 | $14.56 | $10,188.99 |
DisclosureSEC source: 0001437749-23-004978 · rdgdoc.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,715 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F4 · price: Reflects the weighted average price of 700 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 28, 2023 with sale prices ranging from $14.55 to $14.56 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 01:36 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 6,387 | $15.27 | $97,532.68 |
DisclosureSEC source: 0001437749-23-004978 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,415 F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units. F3 · price: Reflects the weighted average price of 6,387 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 27, 2023 with sale prices ranging from $15.00 to $15.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2023 Filed Mar 1, 2023 01:36 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 6,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004978 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,802 F1 · shares: On February 25, 2021, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022. As determined on February 25, 2023, based on actual performance for 2022, the reporting person earned 6,482 PSUs. Of those earned PSUs, one-third, or 2,161 PSUs, vested on February 25, 2023, and the remaining two-thirds, or 4,321 PSUs, are scheduled to vest on February 25, 2024. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:42 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 52,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004565 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,320 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 21:12 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 1,020 | $9.18 | $9,363.70 |
DisclosureSEC source: 0001437749-22-019830 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,707 F1 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 01:27 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 877 | $19.78 | $17,350.39 |
DisclosureSEC source: 0001437749-22-004756 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,727 F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 01:27 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 53,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004756 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,604 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 14:30 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 1,063 | $43.11 | $45,828.16 |
DisclosureSEC source: 0001437749-21-019032 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,667 F1 · shares: The shares were sold to cover taxes associated with the settlement of restricted stock units. F2 · price: Reflects the weighted average price of 1,063 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on August 6, 2021 with sale prices ranging from $43.10 to $43.1622 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 07, 2021 Filed Jul 7, 2021 20:05 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 2,961 | $49.75 | $147,319.82 |
DisclosureSEC source: 0001437749-21-016567 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,730 F1 · shares: The shares were sold to cover taxes associated with the settlement of restricted stock units. F2 · price: Reflects the weighted average price of 2,961 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on July 7, 2021 with sale prices ranging from $49.74 to $49.839 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 21:19 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantEmployee Stock Option (right to buy) · Derivative | 19,456 | $0.00 Strike: $51.60 | $0.00 |
DisclosureSEC source: 0001437749-21-004705 · rdgdoc.xml · derivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,456 Underlying: Common Stock · 19,456 shares Expires 2028-02-25 F2 · derivative.exercise_date: The stock option vests as follows: one-third of the stock option vests on each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 21:19 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 7,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004705 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,691 F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| August 05, 2020 Filed Aug 8, 2020 01:23 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantEmployee Stock Option (right to buy) · Derivative | 24,818 | $0.00 Strike: $36.50 | $0.00 |
DisclosureSEC source: 0001437749-20-017140 · rdgdoc.xml · derivative · entry 4 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,818 Underlying: Common Stock · 24,818 shares Expires 2027-08-05 F4 · derivative.exercise_date: Stock option vests fully on June 30, 2021, subject to the requirement that the Company's stock price exceeds $40.15 for 20 consecutive trading days during the term of the stock option. Read SEC document |
| August 05, 2020 Filed Aug 8, 2020 01:23 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantEmployee Stock Option (right to buy) · Derivative | 26,210 | $0.00 Strike: $36.50 | $0.00 |
DisclosureSEC source: 0001437749-20-017140 · rdgdoc.xml · derivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,210 Underlying: Common Stock · 26,210 shares Expires 2027-08-05 F3 · derivative.exercise_date: One-third of the stock option vests on each of the first three anniversaries of the grant date, subject to the requirement that the Company's stock price exceeds $40.15 for 20 consecutive trading days during the term of the stock option. Read SEC document |
| August 05, 2020 Filed Aug 8, 2020 01:23 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 9,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-017140 · rdgdoc.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,424 F2 · shares: RSUs that vest fully on June 30, 2021. Read SEC document |
| August 05, 2020 Filed Aug 8, 2020 01:23 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 10,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-017140 · rdgdoc.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,178 F1 · shares: Restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,978 | $0.00 Strike: $43.68 | $0.00 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · derivative · entry 13 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,660 Underlying: Common Stock · 4,978 shares Expires 2025-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/13/2017. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,446 | $0.00 Strike: $38.43 | $0.00 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · derivative · entry 12 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,446 shares Expires 2024-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 100% of the shares of stock options will vest on the third anniversary of the grant date of 12/01/2016. F4 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,486 | $0.00 Strike: $32.59 | $0.00 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · derivative · entry 11 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,486 shares Expires 2024-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/14/2016. F4 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,420 | $0.00 Strike: $26.87 | $0.00 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · derivative · entry 10 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,420 shares Expires 2023-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/23/2015. F3 · balance_after: This stock option was previously reported as covering 1,047 shares of common stock at an exercise price of $62.10 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015. F4 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 5,486 | $52.59 | $288,508.74 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 8 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,473 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 5,486 | $32.59 | $178,761.31 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 7 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 10,446 | $52.59 | $549,355.14 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 6 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,473 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 10,446 | $38.43 | $401,387.55 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 5 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 4,978 | $52.59 | $261,793.02 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 4 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,473 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 4,978 | $43.68 | $217,439.04 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 2,420 | $52.59 | $127,267.80 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,473 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 2,420 | $26.87 | $65,013.30 |
DisclosureSEC source: 0001209191-20-028904 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 19,340 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · derivative · entry 10 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,340 Underlying: Common Stock · 19,340 shares Expires 2028-03-13 F2 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 445 | $43.39 | $19,308.55 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 9 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,473 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 612 | $43.39 | $26,554.68 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 8 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,918 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 476 | $43.39 | $20,653.64 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 7 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,530 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 6 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,006 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 184 | $43.39 | $7,983.76 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 5 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,134 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 196 | $43.39 | $8,504.44 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 4 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,318 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 164 | $43.39 | $7,115.96 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,514 Read SEC document |
| February 27, 2020 Filed Mar 17, 2020 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,678 F1 · kind: This transaction involved a gift of securities by the reporting person to his two adult children, who do not share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his two children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children shares for purposes of Section 16 or any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.